Published in J Neurol Neurosurg Psychiatry on January 01, 1995
Multiple treatment comparisons in epilepsy monotherapy trials. Trials (2007) 1.14
Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. Cochrane Database Syst Rev (2001) 0.99
Single Unprovoked Seizures. Curr Treat Options Neurol (2004) 0.98
Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China. Chin Med J (Engl) (2015) 0.90
Antiepileptic drug utilization in children from 1997-2005--a study from the Netherlands. Eur J Clin Pharmacol (2008) 0.85
Time to 12-month remission and treatment failure for generalised and unclassified epilepsy. J Neurol Neurosurg Psychiatry (2013) 0.79
Importance of competing risks in the analysis of anti-epileptic drug failure. Trials (2007) 0.78
The dynamics of drug treatment in epilepsy: an observational study in an unselected population based cohort with newly diagnosed epilepsy followed up prospectively over 11-14 years. J Neurol Neurosurg Psychiatry (2001) 0.78
Drug selection for the newly diagnosed patient: when is a new generation antiepileptic drug indicated? J Neurol (2004) 0.77
Complex Partial Seizures in Adults. Curr Treat Options Neurol (1999) 0.76
Treating refractory epilepsy in adults. BMJ (2006) 0.76
Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy. Pharmaceuticals (Basel) (2010) 0.75
Childhood epilepsy: Management in resource-limited setting. Ann Indian Acad Neurol (2008) 0.75
Phenobarbital for epilepsy: much is still to be learnt. BMJ (2005) 0.75
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55
Chronic antiepileptic toxicity: a review. Epilepsia (1975) 3.70
Monotherapy or polytherapy for epilepsy? Epilepsia (1981) 3.25
Unnecessary polypharmacy for epilepsy. Br Med J (1977) 3.12
Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med (1985) 2.73
The temporal aspects of prognosis in epilepsy. J Neurol Neurosurg Psychiatry (1984) 1.85
A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. J Neurol Neurosurg Psychiatry (1985) 1.51
The prognosis for seizure control in newly diagnosed epilepsy. N Engl J Med (1984) 1.46
A double-blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults. Neurology (1983) 1.06
The course of untreated epilepsy. BMJ (1988) 1.06
Comparison of valproic acid and phenytoin in newly diagnosed tonic-clonic seizures. Neurology (1983) 0.92
Controlled trials in epilepsy: a review. Epilepsia (1982) 0.88
Valproate versus carbamazepine for seizures. N Engl J Med (1993) 0.83
Valproate versus carbamazepine for seizures. N Engl J Med (1993) 0.83
Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet (2011) 10.73
Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med (1978) 9.29
Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet (1975) 7.22
One drug for epilepsy. Br Med J (1978) 4.87
Improvement of medication compliance in uncontrolled hypertension. Lancet (1976) 4.84
Anomalous origin of the left coronary artery from the pulmonary trunk. Its clinical spectrum, pathology, and pathophysiology, based on a review of 140 cases with seven further cases. Circulation (1968) 4.34
One drug (phenytoin) in the treatment of epilepsy. Lancet (1976) 4.32
Mortality from epilepsy: results from a prospective population-based study. Lancet (1994) 4.31
Control of DNA synthesis genes in fission yeast by the cell-cycle gene cdc10+. Nature (1992) 4.13
Chronic antiepileptic toxicity: a review. Epilepsia (1975) 3.70
Pathway correcting DNA replication errors in Saccharomyces cerevisiae. EMBO J (1993) 3.57
Reduction in polypharmacy for epilepsy. Br Med J (1979) 3.56
Coordination of expression of DNA synthesis genes in budding yeast by a cell-cycle regulated trans factor. Nature (1991) 3.53
Coordinated regulation of gene expression by the cell cycle transcription factor Swi4 and the protein kinase C MAP kinase pathway for yeast cell integrity. EMBO J (1996) 3.45
Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet (2005) 3.38
A multicopy suppressor gene of the Saccharomyces cerevisiae G1 cell cycle mutant gene dbf4 encodes a protein kinase and is identified as CDC5. Mol Cell Biol (1993) 3.33
SWI6 protein is required for transcription of the periodically expressed DNA synthesis genes in budding yeast. Nature (1992) 3.32
Monotherapy or polytherapy for epilepsy? Epilepsia (1981) 3.25
Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet (1995) 3.17
Unnecessary polypharmacy for epilepsy. Br Med J (1977) 3.12
Recovery from chronic fatigue syndrome after treatments given in the PACE trial. Psychol Med (2013) 2.82
Drowning in people with epilepsy: how great is the risk? Neurology (2008) 2.80
Enhancement of recovery from psychiatric illness by methylfolate. Lancet (1990) 2.73
P40SDB25, a putative CDK inhibitor, has a role in the M/G1 transition in Saccharomyces cerevisiae. Genes Dev (1994) 2.72
National General Practice Study of Epilepsy: recurrence after a first seizure. Lancet (1990) 2.65
Drug treatment of epilepsy. Lancet (1978) 2.63
Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India. Lancet (1998) 2.58
Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry (2000) 2.53
DNA polymerase II, the probable homolog of mammalian DNA polymerase epsilon, replicates chromosomal DNA in the yeast Saccharomyces cerevisiae. EMBO J (1992) 2.51
Falls in the elderly related to postural imbalance. Br Med J (1977) 2.47
Effects of folic acid on the mental state and fit-frequency of drug-treated epileptic patients. Lancet (1967) 2.42
Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry (2001) 2.40
Anticonvulsant drugs and mental symptoms: a review. Psychol Med (1976) 2.39
The yeast DNA polymerase I transcript is regulated in both the mitotic cell cycle and in meiosis and is also induced after DNA damage. Nucleic Acids Res (1987) 2.38
Infection of the uterine cervix with Chlamydia trachomatis. J Infect Dis (1978) 2.36
Cloning DPB3, the gene encoding the third subunit of DNA polymerase II of Saccharomyces cerevisiae. Nucleic Acids Res (1991) 2.34
Papilloedema and the Landry-Guillain-Barré syndrome. Case reports and a review. Brain (1966) 2.32
Early prognosis of epilepsy. Br Med J (Clin Res Ed) (1982) 2.30
Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun (1989) 2.23
National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population. Lancet (1990) 2.22
The nutrition connection: why doesn't the public know? Am J Public Health (1988) 2.19
Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics. J Neurol Neurosurg Psychiatry (1976) 2.18
Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry (1999) 2.12
Primary hyperparathyroidism: an analysis of failure of parathyroidectomy. World J Surg (2014) 2.09
Is cardiac resuscitation worthwhile? A decade of experience. N Engl J Med (1972) 2.07
Integrated hospital and community psychiatric services and use of inpatient beds. BMJ (1989) 2.03
Aetiology of urinary symptoms in sexually active women. Genitourin Med (1986) 2.03
Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. Hum Mol Genet (1997) 2.02
The forkhead protein Fkh2 is a component of the yeast cell cycle transcription factor SFF. EMBO J (2000) 1.95
Quality of life outcomes of immediate or delayed treatment of early epilepsy and single seizures. Neurology (2007) 1.94
Cranial cruciate ligament rupture. Pathogenesis, diagnosis, and postoperative rehabilitation. Vet Clin North Am Small Anim Pract (1993) 1.89
Results of cardiac resuscitation in 552 patients. Am J Cardiol (1967) 1.88
Expression of the yeast DNA primase gene, PRI1, is regulated within the mitotic cell cycle and in meiosis. Mol Gen Genet (1990) 1.85
Expanded profile of the SHAFT syndrome. J Hand Surg Am (1998) 1.84
Large pragmatic randomised studies of new antiepileptic drugs are needed. BMJ (1997) 1.83
Overlapping and distinct roles of the duplicated yeast transcription factors Ace2p and Swi5p. Mol Microbiol (2001) 1.82
Neurological aspects of folate and vitamin B12 metabolism. Clin Haematol (1976) 1.79
Reticular reflex myoclonus: a physiological type of human post-hypoxic myoclonus. J Neurol Neurosurg Psychiatry (1977) 1.79
Folate deficiency in depressive illness. Br J Psychiatry (1970) 1.79
Order of function of the budding-yeast mitotic exit-network proteins Tem1, Cdc15, Mob1, Dbf2, and Cdc5. Curr Biol (2001) 1.76
Oral contraceptives, depression, and libido. Br Med J (1971) 1.74
Why does epilepsy become intractable? Prevention of chronic epilepsy. Lancet (1983) 1.72
The Skn7 response regulator of Saccharomyces cerevisiae interacts with Hsf1 in vivo and is required for the induction of heat shock genes by oxidative stress. Mol Biol Cell (2000) 1.69
Reversible absorptive defects in anticonvulsant megaloblastic anaemia. J Clin Pathol (1965) 1.68
Cortical reflex myoclonus. Neurology (1979) 1.68
Intracerebral propagation of interictal activity in partial epilepsy: implications for source localisation. J Neurol Neurosurg Psychiatry (1994) 1.66
An epilepsy needs document. Seizure (1993) 1.64
Multiple sclerosis and macrocytosis. Acta Neurol Scand (1990) 1.64
Anticonvulsant therapy, folic acid and vitamin B12 metabolism and mental symptoms. Epilepsia (1966) 1.62
A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain (1982) 1.62
Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology (1991) 1.61
Early treatment and prognosis of epilepsy. Epilepsia (1987) 1.60
Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther (1990) 1.60
A Bub2p-dependent spindle checkpoint pathway regulates the Dbf2p kinase in budding yeast. EMBO J (1999) 1.60
The Swi5 transcription factor of Saccharomyces cerevisiae has a role in exit from mitosis through induction of the cdk-inhibitor Sic1 in telophase. Genetics (1997) 1.59
Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial. Psychol Med (2005) 1.59
The switch mechanism and the bipolar/unipolar dichotomy. Br J Psychiatry (1989) 1.58
Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther (1990) 1.57
Rme1, a negative regulator of meiosis, is also a positive activator of G1 cyclin gene expression. EMBO J (1995) 1.56
The neuropsychiatry of megaloblastic anaemia. Br Med J (1980) 1.56
Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol (2001) 1.56
Power spectrum and intracranial EEG patterns at seizure onset in partial epilepsy. Electroencephalogr Clin Neurophysiol (1995) 1.54
The Nottingham study of neurotic disorder: comparison of drug and psychological treatments. Lancet (1988) 1.53
A general practice records audit of the process of care for people with epilepsy. Br J Gen Pract (1996) 1.53
Depressive symptoms and oral contraceptives. Br Med J (1970) 1.53
Association of the cell cycle transcription factor Mbp1 with the Skn7 response regulator in budding yeast. Mol Biol Cell (1999) 1.53
Serum anticonvulsant concentrations in epileptic patients with mental symptoms. A preliminary report. Br J Psychiatry (1974) 1.51
Predictors of outcome and pathological considerations in the surgical treatment of intractable epilepsy associated with temporal lobe lesions. J Neurol Neurosurg Psychiatry (2001) 1.51
Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives. J Med Chem (1991) 1.50
Vigabatrin and behaviour disturbance. Lancet (1990) 1.50
Water intoxication due to carbamazepine. Br Med J (1977) 1.48
Cognition and survival: an exploration in a large multicentre study of the population aged 65 years and over. Int J Epidemiol (2001) 1.48
Evaluation of fibular head transposition, lateral fabellar suture, and conservative treatment of cranial cruciate ligament rupture in large dogs: a retrospective study. J Am Anim Hosp Assoc (1996) 1.48